223 related articles for article (PubMed ID: 31177655)
1. [The intestinal microflora and cholestatic liver diseases].
Zhu L; Xing HC
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):325-329. PubMed ID: 31177655
[TBL] [Abstract][Full Text] [Related]
2. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease.
Shi Q; Yuan X; Zeng Y; Wang J; Zhang Y; Xue C; Li L
Nutrients; 2023 May; 15(10):. PubMed ID: 37242293
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between bile acid metabolism and chronic non - cholestatic liver disease].
Yan LT; Li JF; Duan ZP; Chen QF
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):151-154. PubMed ID: 29804385
[TBL] [Abstract][Full Text] [Related]
5. Bile Acid Metabolism in Liver Pathobiology.
Chiang JYL; Ferrell JM
Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice.
Isaacs-Ten A; Echeandia M; Moreno-Gonzalez M; Brion A; Goldson A; Philo M; Patterson AM; Parker A; Galduroz M; Baker D; Rushbrook SM; Hildebrand F; Beraza N
Hepatology; 2020 Dec; 72(6):2090-2108. PubMed ID: 32168395
[TBL] [Abstract][Full Text] [Related]
7. Cholestasis impairs gut microbiota development and bile salt hydrolase activity in preterm neonates.
Lynch LE; Hair AB; Soni KG; Yang H; Gollins LA; Narvaez-Rivas M; Setchell KDR; Preidis GA
Gut Microbes; 2023; 15(1):2183690. PubMed ID: 36843227
[TBL] [Abstract][Full Text] [Related]
8. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
9. [The descending pathophysiology model of cholestatic liver disease].
Cai XB; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):321-324. PubMed ID: 31177654
[TBL] [Abstract][Full Text] [Related]
10. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
11. Bile salts and cholestasis.
Maillette de Buy Wenniger L; Beuers U
Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
[TBL] [Abstract][Full Text] [Related]
12. Interactive Relationships between Intestinal Flora and Bile Acids.
Guo X; Okpara ES; Hu W; Yan C; Wang Y; Liang Q; Chiang JYL; Han S
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955473
[TBL] [Abstract][Full Text] [Related]
13. Role of bile acids in liver diseases mediated by the gut microbiome.
Shao JW; Ge TT; Chen SZ; Wang G; Yang Q; Huang CH; Xu LC; Chen Z
World J Gastroenterol; 2021 Jun; 27(22):3010-3021. PubMed ID: 34168404
[TBL] [Abstract][Full Text] [Related]
14. Bile acid transporters: structure, function, regulation and pathophysiological implications.
Alrefai WA; Gill RK
Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
[TBL] [Abstract][Full Text] [Related]
15. Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice.
van der Geest R; Ouweneel AB; van der Sluis RJ; Groen AK; Van Eck M; Hoekstra M
Toxicol Appl Pharmacol; 2016 Sep; 306():1-7. PubMed ID: 27374722
[TBL] [Abstract][Full Text] [Related]
16. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.
Bertolini A; Fiorotto R; Strazzabosco M
Semin Immunopathol; 2022 Jul; 44(4):547-564. PubMed ID: 35415765
[TBL] [Abstract][Full Text] [Related]
17. The ascending pathophysiology of cholestatic liver disease.
Jansen PL; Ghallab A; Vartak N; Reif R; Schaap FG; Hampe J; Hengstler JG
Hepatology; 2017 Feb; 65(2):722-738. PubMed ID: 27981592
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
Nie YF; Hu J; Yan XH
J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
[TBL] [Abstract][Full Text] [Related]
19. The Role of the Gut Microbiota in Bile Acid Metabolism.
Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
[TBL] [Abstract][Full Text] [Related]
20. Interactions between bile salts, gut microbiota, and hepatic innate immunity.
Schubert K; Olde Damink SWM; von Bergen M; Schaap FG
Immunol Rev; 2017 Sep; 279(1):23-35. PubMed ID: 28856736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
